GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing a collaboration with NXP Semiconductors focused on edge AI concepts for anesthesia delivery and neonatal monitoring, with both concepts scheduled to be showcased at CES 2026.

The edge AI announcement lands after a strong run in the shares, with a 90 day share price return of 24.15% and a 1 year total shareholder return of 2.43%. This suggests that near term momentum has picked up while longer term gains remain more moderate.

If GE HealthCare’s AI push has your attention, this could be a helpful moment to see what else is happening across healthcare stocks as you broaden your watchlist.

With GE HealthCare trading at US$88.16, sitting about 3% below the average analyst target and carrying an indicated intrinsic discount near 37%, investors may ask whether there is still potential upside or whether the market has already fully priced in future growth.

Most Popular Narrative: 1.2% Undervalued

With GE HealthCare closing at US$88.16 against a narrative fair value near US$89.22, the story points to a small valuation gap grounded in detailed earnings and margin work.

The analysts have a consensus price target of $88.0 for GE HealthCare Technologies based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $106.0, and the most bearish reporting a price target of just $73.0.

Curious what earnings path, revenue cadence and profit margins sit behind that tight fair value range? The narrative focuses on specific mid term targets and a defined earnings multiple. It is useful to see which assumptions really drive the model.

Result: Fair Value of $89.22 (UNDERVALUED)

However, that earnings path still depends on tariffs easing and China remaining a workable market, and any stumble there could quickly challenge the current fair value story.

Build Your Own GE HealthCare Technologies Narrative

If you see the numbers differently, or prefer to test your own assumptions against the data, you can build a fresh GE HealthCare view in a few minutes: Do it your way

A great starting point for your GE HealthCare Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If GE HealthCare is already on your radar, this is a good moment to broaden your options and line up a few more ideas worth watching.

• Spot potential high growth names early by scanning these 3545 penny stocks with strong financials that already show stronger financial footing than many expect from lower priced shares.
• Position yourself where data and automation meet by using these 29 healthcare AI stocks to find companies applying AI to real world medical problems.
• Strengthen your income watchlist by reviewing these 11 dividend stocks with yields > 3% that may offer more consistent cash returns than you get from price moves alone.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.